Palatin Technologies
PTN
#9949
Rank
โ‚ฌ30.6 M
Marketcap
17,97ย โ‚ฌ
Share price
-17.85%
Change (1 day)
2,172.64%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ4.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ8.84 Million. In 2024 the company made an earning of -โ‚ฌ22.93 Million, an increase over its 2023 earnings that were of -โ‚ฌ27.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ4.7 Million-79.54%
2024 -โ‚ฌ22.93 Million-16.9%
2023 -โ‚ฌ27.59 Million5.99%
2022 -โ‚ฌ26.03 Million-13.7%
2021 -โ‚ฌ30.16 Million33.25%
2020 -โ‚ฌ22.64 Million-172.11%
2019 โ‚ฌ31.38 M2352.33%
2018 โ‚ฌ1.27 M-94.13%
2017 โ‚ฌ21.8 M-154.92%
2016 -โ‚ฌ39.71 Million3.67%
2015 -โ‚ฌ38.31 Million878%
2014 -โ‚ฌ3.92 Million-72.64%
2013 -โ‚ฌ14.32 Million-33.11%
2012 -โ‚ฌ21.4 Million77.71%
2011 -โ‚ฌ12.05 Million
2003 -โ‚ฌ20.4 Million29.93%
2002 -โ‚ฌ15.7 Million36.18%
2001 -โ‚ฌ11.53 Million
1999 -โ‚ฌ9.57 Million6.04%
1998 -โ‚ฌ9.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚ฌ10.22 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.1 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.49 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ43.01 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ56.84 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.56 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ47.28 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.13 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK